How many insider declarations has Rappaport Andrew filed?

Rappaport Andrew has filed 2 public insider declarations with SEC (Form 4).

What is Rappaport Andrew's role?

Rappaport Andrew's reported role is not specified by the regulator across the filings.

Which companies does Rappaport Andrew report trades for?

Rappaport Andrew reports trades for Olema Pharmaceuticals, Inc..

← Executives ★ Sign in to follow

RA

Rappaport Andrew

OFFICER

·SEC (Form 4)

Olema Pharmaceuticals, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by Rappaport Andrew. Director active across 1 company, notably Olema Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been logged. Activity tracked since 5 March 2024. The latest transaction was disclosed on 21 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Rappaport Andrew

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Olema Pharmaceuticals, Inc. (US)

Declarations2 total

◇

RAPPAPORT ANDREW

DirectorExecutives21 Nov 2025Olema Pharmaceuticals, Inc.

$13,98919SEC ↗

35,868 shares@ US$0.39100.0% of flowCommon StockSEC:0001162157-25-000005:0

●